Lifirafenib (BGB-283) - CD BioSciences

service-banner

Lifirafenib (BGB-283)

Lifirafenib (BGB-283)

SPC-01240

Lifirafenib (BGB-283)

CAS No. 1446090-79-4

Size Price
5 mg Online Inquiry
25 mg Online Inquiry
Bulk Size Online Inquiry

Raf inhibitor ; EGFR inhibitor

Description
Lifirafenib (BGB-283, Beigene-283) potently inhibits RAF family kinases and EGFR activities in biochemical assays with IC50 values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.
Product Details
CAS No. CAS No. 1446090-79-4
Description Lifirafenib (BGB-283, Beigene-283) potently inhibits RAF family kinases and EGFR activities in biochemical assays with IC50 values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.
Formula C25H17F3N4O3
Molecular Weight 478.42
Storage 3 years -20°C powder
2 years -80°C in solvent
Synonyms Beigene-283
SMILES C1CC(=O)NC2=NC=CC(=C21)OC3=CC4=C(C=C3)OC5C4C5C6=NC7=C(N6)C=C(C=C7)C(F)(F)F
Usage
Storage 3 years -20°C powder
2 years -80°C in solvent

For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.